The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community…
| Price | $0.03 |
|---|---|
| Market cap | $2.76M |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| Exchange | NASDAQ |
| 52-week range | 0.0276-0.03 |
| Beta | 2.64 |
Explore STLNW's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.